Total Payments
$4,953
2024 Payments
$609.49
Companies
26
Transactions
176
Medicare Patients
3,493
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$4,911 (99.1%)
Other$23.07 (0.5%)
Gifts$19.40 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,911 | 172 | 99.1% |
| Honoraria | $23.07 | 3 | 0.5% |
| Gift | $19.40 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $897.17 | 22 | $0 (2024) |
| Alimera Sciences, Inc. | $817.93 | 36 | $0 (2023) |
| Genentech USA, Inc. | $615.92 | 21 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $548.11 | 16 | $0 (2021) |
| Apellis Pharmaceuticals, Inc. | $330.64 | 7 | $0 (2024) |
| EyePoint Pharmaceuticals US, Inc. | $304.64 | 11 | $0 (2023) |
| Kala Pharmaceuticals, Inc. | $232.61 | 12 | $0 (2022) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $168.72 | 4 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $125.00 | 1 | $0 (2021) |
| Mallinckrodt Enterprises LLC | $119.57 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $609.49 | 21 | Genentech USA, Inc. ($184.24) |
| 2023 | $905.13 | 27 | Alimera Sciences, Inc. ($217.36) |
| 2022 | $802.46 | 30 | EyePoint Pharmaceuticals US, Inc. ($170.93) |
| 2021 | $602.93 | 27 | Alimera Sciences, Inc. ($153.84) |
| 2020 | $363.65 | 20 | Alimera Sciences, Inc. ($110.35) |
| 2019 | $622.93 | 24 | Novartis Pharmaceuticals Corporation ($276.95) |
| 2018 | $666.84 | 14 | Regeneron Healthcare Solutions, Inc. ($359.93) |
| 2017 | $379.72 | 13 | Novartis Pharmaceuticals Corporation ($121.91) |
All Payment Transactions
176 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Amgen Inc. | PAVBLU (Biological) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Ophthalmology | ||||||
| 12/10/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Ophthalmology | ||||||
| 11/19/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/15/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Ophthalmology | ||||||
| 11/05/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/24/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $32.71 | General |
| Category: Ophthalmology | ||||||
| 10/03/2024 | Harrow Eye, LLC | IHEEZO (Drug), TRIESENCE | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: OPTOMETRY | ||||||
| 09/22/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Ophthalmology | ||||||
| 08/27/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/02/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Ophthalmology | ||||||
| 07/26/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: Ophthalmology | ||||||
| 06/25/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $35.72 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/15/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $117.05 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/30/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Ophthalmology | ||||||
| 04/12/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Ophthalmology | ||||||
| 03/26/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/22/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $34.64 | General |
| Category: EYE CARE | ||||||
| 02/01/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Ophthalmology | ||||||
| 01/24/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $31.34 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/05/2024 | Coherus Biosciences Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Ophthalmology | ||||||
| 12/07/2023 | Thea Pharma Inc. | IYUZEH (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/16/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/14/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $36.34 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/25/2023 | Thea Pharma Inc. | IYUZEH (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 886 | 2,252 | $635,200 | $237,926 |
| 2022 | 10 | 849 | 2,596 | $733,923 | $282,266 |
| 2021 | 10 | 883 | 2,681 | $674,928 | $262,748 |
| 2020 | 8 | 875 | 2,356 | $559,025 | $228,688 |
Total Patients
3,493
Total Services
9,885
Medicare Billing
$1.0M
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 24 | 180 | $252,000 | $124,033 | 49.2% |
| 67028 | Injection of drug into eye | Office | 2023 | 91 | 451 | $229,670 | $42,713 | 18.6% |
| 92134 | Imaging of retina | Office | 2023 | 275 | 827 | $53,755 | $23,373 | 43.5% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 202 | 207 | $28,980 | $16,110 | 55.6% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 49 | 281 | $42,150 | $14,945 | 35.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 110 | $11,330 | $7,016 | 61.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 66 | 80 | $7,600 | $4,483 | 59.0% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 39 | 39 | $7,020 | $3,896 | 55.5% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 65 | 77 | $2,695 | $1,358 | 50.4% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 22 | 206 | $288,400 | $147,741 | 51.2% |
| 67028 | Injection of drug into eye | Office | 2022 | 97 | 487 | $243,600 | $45,861 | 18.8% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 58 | 650 | $97,500 | $34,128 | 35.0% |
| 92134 | Imaging of retina | Office | 2022 | 250 | 793 | $51,545 | $23,462 | 45.5% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 195 | 196 | $27,440 | $16,059 | 58.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 88 | $9,064 | $5,287 | 58.3% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 78 | 84 | $7,980 | $5,071 | 63.6% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 24 | 24 | $4,320 | $2,593 | 60.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 14 | $2,184 | $1,103 | 50.5% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2022 | 47 | 54 | $1,890 | $960.56 | 50.8% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2021 | 22 | 162 | $226,800 | $118,863 | 52.4% |
| 67028 | Injection of drug into eye | Office | 2021 | 96 | 476 | $229,600 | $46,127 | 20.1% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2021 | 63 | 708 | $106,200 | $40,153 | 37.8% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 271 | 844 | $54,860 | $23,997 | 43.7% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 188 | 191 | $26,740 | $15,773 | 59.0% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 123 | 174 | $16,530 | $10,293 | 62.3% |
About Dr. Joseph Murphy, MD
Dr. Joseph Murphy, MD is a Ophthalmology healthcare provider based in Williamsville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730158924.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Murphy, MD has received a total of $4,953 in payments from pharmaceutical and medical device companies, with $609.49 received in 2024. These payments were reported across 176 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($4,911).
As a Medicare-enrolled provider, Murphy has provided services to 3,493 Medicare beneficiaries, totaling 9,885 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Williamsville, NY
- Active Since 03/17/2006
- Last Updated 01/06/2026
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1730158924
Products in Payments
- ILUVIEN (Drug) $513.93
- EYLEA AFLIBERCEPT INJECTION (Biological) $478.08
- Vabysmo (Drug) $376.95
- YUTIQ (Drug) $286.95
- Iluvien (Drug) $235.99
- INVELTYS (Drug) $232.61
- EYLEA (Biological) $232.50
- Syfovre (Drug) $195.55
- BEOVU (Drug) $187.32
- EYLEA HD (Biological) $186.59
- ACTHAR (Biological) $158.57
- Cimerli (Biological) $156.49
- Lucentis (Biological) $148.92
- JARDIANCE (Drug) $125.00
- ENTRESTO (Drug) $121.91
- XIPERE (Drug) $107.91
- VYZULTA (Drug) $100.00
- Izervay (Drug) $79.52
- OZURDEX (Drug) $66.09
- VABYSMO (Drug) $52.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Williamsville
Dr. Daniel Cotter, M.d, M.D
Ophthalmology — Payments: $48,021
Ophthalmology $48,021
Charles Niles, M.d, M.D
Ophthalmology — Payments: $14,541
Ophthalmology $14,541
John Legarreta, M.d, M.D
Ophthalmology — Payments: $9,822
Ophthalmology $9,822
Dr. Andrew Siedlecki, Md, MD
Ophthalmology — Payments: $9,078
Ophthalmology $9,078
Stephen Pollack, Md, MD
Ophthalmology — Payments: $6,707
Ophthalmology $6,707
Dr. Paul Lee
Ophthalmology — Payments: $5,956
Ophthalmology $5,956